For Men with Prostate Cancer, Sex Still Matters

Canadians underestimate difficulty of coping with prostate cancer's impact on 
sex life 
TORONTO, Nov. 29, 2012 /CNW/ - Two recent Leger Marketing surveys probing 
Canadians' perceptions of the most difficult things to deal with if faced with 
a diagnosis of prostate cancer illustrate a significant gap in appreciating 
quality of life issues associated with the disease. 
For instance, according to the surveys, while Canadians in general (32%) and 
men who have had, or currently have, prostate cancer (37%) both rated worrying 
or losing hope as the hardest single thing to deal with, the two groups had 
a significantly different understanding of the importance of the impact of 
prostate cancer on a man's sex life. 
The surveys also suggest men who have or had prostate cancer rated their sex 
life as the second most difficult thing to deal with when facing a diagnosis 
of prostate cancer (23%) whereas Canadian men ranked sex life as sixth overall 
(4%). Of those affected by prostate cancer, men from Atlantic Canada (32%) and 
Ontario (28%) are more likely to worry about their sex lives after their 
prostate cancer diagnosis compared to those in Quebec (15%). 
"Prostate cancer can affect men on a number of levels," says Dr. Jean-Baptiste 
Lattouf, MD, FRCS (C) uro-oncologist, laparoscopist, assistant professor at 
the Surgery Department of the Hospital Center of the University of Montreal 
(CHUM). "The disease can most definitely impact a man's sexual relationship 
with his partner, but I also think the issue of hope is an important one. It 
challenges us to better understand how we can help men, whether it's through 
better information, new or improved treatments, or stronger support, during 
their cancer journey." 
Jackie Manthorne, president and CEO of the Canadian Cancer Survivors Network 
(CCSN), concurs. "This survey highlights a number of important points," says 
Manthorne. "We know that sexual intimacy is an ongoing challenge for many 
prostate cancer patients, and indeed, cancer patients in general. Healthcare 
professionals need to ensure they take time to encourage patients to express 
their concerns. Quality of life issues are very real for prostate cancer 
patients and survivors and they need to be better understood and managed." 
The results indicate feeling embarrassed, knowing their illness has an impact 
on loved ones, and being unable to access new and better treatments round out 
prostate cancer sufferers' top five ranking of their most difficult issues. 
Talking about prostate cancer 
According to the survey, most men are comfortable discussing with others the 
fact they have or have had prostate cancer and are not embarrassed to tell 
people about it.( )In addition, 83% of respondents agreed that people around 
them are sympathetic about their condition.( ) 
But for the Canadians who have had to deal with a diagnosis of prostate 
cancer, the survey reports as many as 30% feel that the people around them do 
not think that prostate cancer is important.( )Additionally, 44% of 
respondents agree that their family and friends don't understand how serious a 
disease prostate cancer is.( ) 
"We need to continue educating people about the seriousness of the disease," 
says Manthorne. "It is true that many people live long and fulfilling lives 
with prostate cancer, but others aren't so lucky. Prostate cancer is still 
cancer. It needs to be taken seriously." 
Regional findings from this survey: 

    --  87% of men are comfortable discussing with others that they
        have or have had prostate cancer; the same proportion says they

    are not embarrassed to tell people about it.( )
  o Men who are married are less likely to be comfortable discussing 
that they have/had prostate cancer with others compared to men who 
are single, widowed, divorced or separated (85% vs. 93%).
  o Regionally, men from Atlantic Canada are the most likely to feel 
comfortable discussing this with others (98% vs. 86% rest of 
Canada).( )
  o Men from Quebec are the most likely to feel embarrassed about their 

    diagnosis (40% vs. 15% rest of Canada).( )
    --  83% of men who have or have had prostate cancer agree that

    people around them are sympathetic about their condition.( )
  o Regionally, men from B.C. (92%) are more likely to agree that 
people around them are sympathetic towards their condition compared 
to men from Quebec (81%) and Atlantic Canada (77%). 
"We continue to make strides in our understanding of the disease from both a 
medical and social perspective," says Dr. Lattouf. "Ongoing dialogue will only 
help our progress to better understand what men need to successfully address 
their challenges during and after their treatment." 
About the Research 
The survey, commissioned by Astellas Pharma Canada, Inc., was completed online 
by Leger Marketing from October 3, 2012 to October 9, 2012 with a sample of 
603 Canadian men who currently have or have had prostate cancer. A previous 
survey completed online from July 30, 2012 to August 1, 2012, with a sample of 
1500 Canadians, was used for comparison. 
A probability sample for men who have/had prostate cancer of the same size 
would yield a margin of error of ±2.5 %, 19 times out of 20. A probability 
sample for Canadians in general of the same size would yield a margin of error 
of ± 4.0%, 19 times out of 20. 
About the Canadian Cancer Survivor Network (CCSN) 
The Canadian Cancer Survivor Network was created by a group of Canadians 
concerned about cancer.CCSN's mission is to empower collaborative action by 
cancer patients, families and communities to identify and work to remove 
barriers to optimal patient care, and to ensure that cancer survivors have 
access to education and action opportunities to have their voices heard in 
planning and implementing an optimal health care system.CCSN is committed to 
educate the public and policy makers about the financial, emotional and health 
costs of cancer and offer considered, positive ideas and recommendations to 
alleviate their effects. To learn more, visit 
Astellas Pharma Canada, Inc. 
Astellas Pharma Canada, Inc., headquartered in Markham, ON, is a Canadian 
affiliate of Tokyo-based Astellas Pharma Inc. 
Astellas is a pharmaceutical company dedicated to improving the health of 
people around the world through the provision of innovative and reliable 
pharmaceutical products. 
The organization is committed to becoming a global category leader in focused 
areas by combining outstanding R&D and marketing capabilities. 
In Canada, Astellas has an intense commercial focus on five therapeutic areas 
- Urology, Immunology, Infectious Disease, Dermatology and Oncology. 
For more information about Astellas Pharma Canada, Inc., please visit the 
corporate website: 
about this release or to book an interview with a medical expert, please  call: 
Stephanie Fitch energi PR 416-425-9143 ext. 17 
SOURCE: Astellas Pharma Canada, Inc. 
To view this news release in HTML formatting, please use the following URL: 
CO: Astellas Pharma Canada, Inc.
ST: Ontario
-0- Nov/29/2012 13:00 GMT
Press spacebar to pause and continue. Press esc to stop.